| Mark Edward Vig, MD | |
|
520 Douglas Blvd, Tyler, TX 75702-8307 | |
| (903) 593-1721 | |
| Not Available |
| Full Name | Mark Edward Vig |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 520 Douglas Blvd, Tyler, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023251527 | NPI | - | NPPES |
| 8GK658 | Other | TX | BCBS |
| 369865601 | Medicaid | TX | |
| 75-2616977-007 | Other | TX | TRICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus Homecare | Tyler, TX | Home health agency |
| Christus Mother Frances Hospital | Tyler, TX | Hospital |
| Ut Health East Texas Tyler Regional Hospital | Tyler, TX | Hospital |
| Christus Mother Frances Hospital- Jacksonville | Jacksonville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christus Trinity Clinic | 3072426741 | 1227 |
News Archive
A widely available drug may be effective in treating kidney disease, report scientists at the University of California, Santa Barbara. They describe the discovery in the online edition of the Proceedings of the National Academies of Science.
The New York Stem Cell Foundation Research Institute and the Personal Genomes Project today announced the availability of a unique new stem cell resource for scientists around the world.
Patients with a type of lung cancer called non-squamous non-small cell lung cancer (non-SQ NSCLC) have limited treatment options and a dismal prognosis once their disease has advanced and initial treatment with platinum-based chemotherapy has failed. Second-line treatment is usually with another chemotherapy drug, such as docetaxel or pemetrexed.
According to a new study, a novel composite measure consisting of 29 alcohol policies demonstrates that a strong alcohol policy environment is a protective factor against binge drinking in the U.S.
› Verified 2 days ago
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
A widely available drug may be effective in treating kidney disease, report scientists at the University of California, Santa Barbara. They describe the discovery in the online edition of the Proceedings of the National Academies of Science.
The New York Stem Cell Foundation Research Institute and the Personal Genomes Project today announced the availability of a unique new stem cell resource for scientists around the world.
Patients with a type of lung cancer called non-squamous non-small cell lung cancer (non-SQ NSCLC) have limited treatment options and a dismal prognosis once their disease has advanced and initial treatment with platinum-based chemotherapy has failed. Second-line treatment is usually with another chemotherapy drug, such as docetaxel or pemetrexed.
According to a new study, a novel composite measure consisting of 29 alcohol policies demonstrates that a strong alcohol policy environment is a protective factor against binge drinking in the U.S.
› Verified 2 days ago
| Entity Name | Mother Frances Hospital Jacksonville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952306672 PECOS PAC ID: 5597751024 Enrollment ID: O20040421001092 |
News Archive
A widely available drug may be effective in treating kidney disease, report scientists at the University of California, Santa Barbara. They describe the discovery in the online edition of the Proceedings of the National Academies of Science.
The New York Stem Cell Foundation Research Institute and the Personal Genomes Project today announced the availability of a unique new stem cell resource for scientists around the world.
Patients with a type of lung cancer called non-squamous non-small cell lung cancer (non-SQ NSCLC) have limited treatment options and a dismal prognosis once their disease has advanced and initial treatment with platinum-based chemotherapy has failed. Second-line treatment is usually with another chemotherapy drug, such as docetaxel or pemetrexed.
According to a new study, a novel composite measure consisting of 29 alcohol policies demonstrates that a strong alcohol policy environment is a protective factor against binge drinking in the U.S.
› Verified 2 days ago
| Entity Name | Mother Frances Hospital Regional Health Care Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679578439 PECOS PAC ID: 9234025636 Enrollment ID: O20040610001042 |
News Archive
A widely available drug may be effective in treating kidney disease, report scientists at the University of California, Santa Barbara. They describe the discovery in the online edition of the Proceedings of the National Academies of Science.
The New York Stem Cell Foundation Research Institute and the Personal Genomes Project today announced the availability of a unique new stem cell resource for scientists around the world.
Patients with a type of lung cancer called non-squamous non-small cell lung cancer (non-SQ NSCLC) have limited treatment options and a dismal prognosis once their disease has advanced and initial treatment with platinum-based chemotherapy has failed. Second-line treatment is usually with another chemotherapy drug, such as docetaxel or pemetrexed.
According to a new study, a novel composite measure consisting of 29 alcohol policies demonstrates that a strong alcohol policy environment is a protective factor against binge drinking in the U.S.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Edward Vig, MD Po Box 846098, Dallas, TX 75284-6098 Ph: (903) 324-6400 | Mark Edward Vig, MD 520 Douglas Blvd, Tyler, TX 75702-8307 Ph: (903) 593-1721 |
News Archive
A widely available drug may be effective in treating kidney disease, report scientists at the University of California, Santa Barbara. They describe the discovery in the online edition of the Proceedings of the National Academies of Science.
The New York Stem Cell Foundation Research Institute and the Personal Genomes Project today announced the availability of a unique new stem cell resource for scientists around the world.
Patients with a type of lung cancer called non-squamous non-small cell lung cancer (non-SQ NSCLC) have limited treatment options and a dismal prognosis once their disease has advanced and initial treatment with platinum-based chemotherapy has failed. Second-line treatment is usually with another chemotherapy drug, such as docetaxel or pemetrexed.
According to a new study, a novel composite measure consisting of 29 alcohol policies demonstrates that a strong alcohol policy environment is a protective factor against binge drinking in the U.S.
› Verified 2 days ago
Ifeatu Uchenna Oti, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 Medical Dr, Tyler, TX 75701 Phone: 903-595-5486 Fax: 903-595-5128 | |
Preetham Reddy Muskula, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2608 Mcdonald Rd, Tyler, TX 75701 Phone: 903-595-5514 Fax: 903-262-3715 | |
Dr. Varalaxmi Bhavani Nannaka, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 912 S Fleishel Ave, Tyler, TX 75701 Phone: 903-592-6901 | |
David A Brickey, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 E Dawson St, Tyler, TX 75701 Phone: 903-525-1914 | |
Randy Craig Randall, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1783 Troup Highway, Tyler, TX 75701 Phone: 903-595-2283 Fax: 903-595-1063 | |
Nabeel K Ahmed, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 Medical Dr, Tyler, TX 75701 Phone: 903-595-5486 Fax: 903-595-5128 | |
Dr. Amanda Nicole Long, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 619 S Fleishel Ave, Ste 327, Tyler, TX 75701 Phone: 903-510-1173 |